Marvell Rises 3% After Monday’s 7% Drop: Is the Lumentum Deal Still Worth the Dilution Risk?

Semiconductors

Marvell Rebounds 3% but Lumentum Dilution Question Stays Open

Marvell trades at $149.06, up 3%, after a 7% Monday drop. A $2 billion preferred issue and a 7% hyperscaler warrant keep Lumentum dilution risk alive.

By
Sophie Lindqvist
Filed
Channel
Semiconductors
Read
3 min read

Marvell Technology (NASDAQ:MRVL) trades at $149.06, up 3 percent, one day after a 7 percent slide that took the stock to a $145.36 close on Monday, November 16. The rebound settles nothing about the pending Lumentum acquisition. Dilution risk remains on the table.

The recovery lines up with a 13F filing. Citadel sharply increased its Marvell stake, according to the quarterly holdings report that large money managers file with the Securities and Exchange Commission. Those filings capture positions as of September 30. They say nothing about what Citadel owns today. The market read the disclosure as support. It is a lagging signal, not a fresh one.

Why did Marvell fall harder than chip peers?

Chip stocks sold off broadly on November 16, ahead of NVIDIA's (NASDAQ:NVDA) results and Anthropic's expected trading debut. The S&P 500 slid alongside them. Marvell dropped 7 percent.

The drop came despite same-day news. Marvell announced a collaboration with Penguin Solutions (NASDAQ:PENG) covering AI memory and photonic memory technology for data center inference. Fresh product news failed to hold the stock. That points to broad risk appetite as the main force behind the slide, not company-specific weakness.

Broadcom (NASDAQ:AVGO) sits at $340.40, up 2 percent, tracking Marvell's direction. NVIDIA trades at $155.41, down 0.5 percent before earnings. It is the only name in the group trading lower. That cuts against the idea of a uniform chip rebound.

How does Marvell's business stand apart?

Marvell is a fabless designer focused on custom silicon and data center connectivity, from optics to Ethernet switches. Acquisitions of Celestial AI and XConn Technologies closed in February and deepened its position in photonic and chiplet interconnect.

Broadcom pairs custom AI accelerators and networking chips with a large infrastructure software arm that includes VMware. NVIDIA sells full accelerated computing platforms built around its CUDA software ecosystem. Marvell is the more concentrated play. It targets the plumbing inside AI data centers.

What does the Lumentum deal actually cost?

Lumentum Holdings (NASDAQ:LITE) trades at $572.55, up 5 percent, after a Reuters report that the United States is moving ahead with curbs on imports of new Chinese optical transceivers. A B. Riley note said Lumentum's value now depends on how Marvell stock trades. That puts dilution at the center of the deal debate.

The bulls see added scale in optical interconnect, a business Marvell management already ranks among its strongest. The chief executive said on the August 27 earnings call: "Connectivity clearly is a driver." He added that the business "continues to be absolutely on fire."

The bears point to share dilution, regulatory review and the work of integrating a large optical business. Equity commitments already sit on Marvell's books. The company issued $2 billion of Series A Convertible Preferred Stock on March 31. It also granted a key hyperscaler a warrant to acquire up to 7 percent of its shares, tied to revenue milestones. The chief financial officer addressed the point on the same call: "we intend to continue repurchasing shares to manage dilution." A promise of buybacks is not a completed buyback.

The data center segment carried the numbers behind that confidence. It made up 79 percent of revenue in Q2 FY2027 and grew 46 percent year over year, per Marvell's second-quarter results. The chief executive guided to data center revenue growth of "roughly 75 percent year-over-year" for the following quarter. Guidance is guidance. It is not booked revenue.

What comes next?

Marvell's upcoming earnings will test whether custom silicon and connectivity demand hold up while the Lumentum review is pending. A stronger Marvell share price could ease dilution concerns, since B. Riley ties Lumentum's value directly to Marvell stock. Further chip weakness, a drawn-out regulatory review or a rough integration would cut the other way for existing owners, and those risks could weigh on the shares until the review concludes.

Source: 247wallst.com

Share this article:

More from Sophie Lindqvist

Sophie Lindqvist

Show full bio

News editor covering money, funding and market shifts around Semiconductors, chip manufacturing, hardware, AI compute at Chip Dispatch.

1,086 articles

Related articles

« Previous article